Technical Analysis for AUPH - Aurinia Pharmaceuticals Inc

Grade Last Price % Change Price Change
grade C 6.06 -1.78% -0.11
AUPH closed down 1.78 percent on Friday, September 20, 2019, on 1.46 times normal volume. It was able to find support at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
5 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Flat Down
See historical AUPH trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
50 DMA Support Bullish 0.00%
Crossed Above 20 DMA Bullish -1.78%
Crossed Above 50 DMA Bullish -1.78%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.78%
Fell Below 200 DMA Bearish 2.36%
Fell Below 20 DMA Bearish 2.36%
Fell Below 50 DMA Bearish 2.36%
Down 3 Days in a Row Weakness 2.36%
200 DMA Support Bullish -5.02%

Older signals for AUPH ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
AUPH Chart by TradingView
Basic chart:
Profile
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development of a therapeutic drug to treat autoimmune diseases in Canada. The company's lead drug includes Voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis. It has a development and license agreement with 3SBio Inc. for the clinical development, registration, and commercialization of voclosporin in China; and licensing and collaboration agreement with Vifor Pharma for the treatment of lupus and various proteinuric nephrology indications. The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. Aurinia Pharmaceuticals Inc. was founded in 1993 and is headquartered in Victoria, Canada.
Medicine Biopharmaceutical Life Sciences Drugs Autoimmune Diseases Immunosuppressants Peptides Lupus Lupus Nephritis Treatment Of Lupus
Is AUPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Sep 16 22 Healthcare Stocks Moving In Monday's Pre-Market Session
Sep 14 Aurinia Pharma inks $40M stock sales deal with Jefferies
Sep 13 EGO, OAS and AOBC among notable after hours movers
Sep 13 Aurinia Establishes At-the-Market Facility
Sep 10 Benzinga's Top Upgrades, Downgrades For September 10, 2019
Sep 10 Bernstein upgrades Ionis in premarket analyst action
Sep 9 Microcaps dominate after hour movers
Sep 6 Aurinia Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference
Aug 29 Aurinia And Voclosporin In Lupus Nephritis: The Countdown Begins
Aug 22 Aurinia Pharmaceuticals Inc. (TSE:AUP): A Fundamentally Attractive Investment
See more AUPH news...
Indicators
Indicator Value
52 Week High 7.85
52 Week Low 5.06
Average Volume 547,519
200-Day Moving Average 6.3413
50-Day Moving Average 6.0446
20-Day Moving Average 5.9965
10-Day Moving Average 6.283
Average True Range 0.2843
ADX 21.95
+DI 18.2501
-DI 19.7624
Chandelier Exit (Long, 3 ATRs ) 5.7771
Chandelier Exit (Short, 3 ATRs ) 6.3929
Upper Bollinger Band 6.6894
Lower Bollinger Band 5.3036
Percent B (%b) 0.55
BandWidth 23.110148
MACD Line 0.0766
MACD Signal Line 0.0628
MACD Histogram 0.0138
Fundamentals Value
Market Cap 505.92 Million
Num Shares 83.5 Million
EPS -1.30
Price-to-Earnings (P/E) Ratio -4.66
Price-to-Sales 1112.47
Price-to-Book 2.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.59
Resistance 3 (R3) 6.63 6.50 6.50
Resistance 2 (R2) 6.50 6.37 6.48 6.47
Resistance 1 (R1) 6.28 6.28 6.22 6.24 6.44
Pivot Point 6.15 6.15 6.12 6.13 6.15
Support 1 (S1) 5.93 6.02 5.87 5.89 5.68
Support 2 (S2) 5.80 5.93 5.78 5.65
Support 3 (S3) 5.58 5.80 5.62
Support 4 (S4) 5.54